{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:22:05Z","timestamp":1787239325019,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.eprac.2022.10.005","type":"journal-article","created":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T01:59:44Z","timestamp":1666144784000},"page":"148-153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Active Surveillance for Low-Risk Differentiated Thyroid Cancer"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0566-6771","authenticated-orcid":false,"given":"Sara","family":"Ahmadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik K.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.eprac.2022.10.005_bib1","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1089\/thy.2015.0313","article-title":"Incidences of unfavorable events in the management of low-risk papillary microcarcinoma of the thyroid by active surveillance versus immediate surgery","volume":"26","author":"Oda","year":"2016","journal-title":"Thyroid"},{"issue":"4","key":"10.1016\/j.eprac.2022.10.005_bib2","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1089\/105072503321669875","article-title":"An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid","volume":"13","author":"Ito","year":"2003","journal-title":"Thyroid"},{"issue":"3","key":"10.1016\/j.eprac.2022.10.005_bib3","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/s00268-015-3392-y","article-title":"Clinical trials of active surveillance of papillary microcarcinoma of the thyroid","volume":"40","author":"Miyauchi","year":"2016","journal-title":"World J Surg"},{"issue":"1","key":"10.1016\/j.eprac.2022.10.005_bib4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1089\/thy.2013.0367","article-title":"Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation","volume":"24","author":"Ito","year":"2014","journal-title":"Thyroid"},{"issue":"6","key":"10.1016\/j.eprac.2022.10.005_bib5","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1007\/s00268-009-0359-x","article-title":"Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized: our treatment strategies and outcomes","volume":"34","author":"Sugitani","year":"2010","journal-title":"World J Surg"},{"issue":"3","key":"10.1016\/j.eprac.2022.10.005_bib6","doi-asserted-by":"crossref","first-page":"e172","DOI":"10.1210\/clinem\/dgz113","article-title":"Active surveillance in papillary thyroid microcarcinomas is feasible and safe: experience at a single Italian center","volume":"105","author":"Molinaro","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.eprac.2022.10.005_bib7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1089\/thy.2018.0462","article-title":"Active surveillance for T1bN0M0 papillary thyroid carcinoma","volume":"29","author":"Sakai","year":"2019","journal-title":"Thyroid"},{"issue":"1","key":"10.1016\/j.eprac.2022.10.005_bib8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1530\/EJE-17-0160","article-title":"Clinical outcomes after delayed thyroid surgery in patients with papillary thyroid microcarcinoma","volume":"177","author":"Jeon","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"10.1016\/j.eprac.2022.10.005_bib9","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1007\/s00268-014-2498-y","article-title":"Revisiting the guidelines issued by the Japanese Society of Thyroid Surgeons and Japan Association of Endocrine Surgeons: a gradual move towards consensus between Japanese and western practice in the management of thyroid carcinoma","volume":"38","author":"Takami","year":"2014","journal-title":"World J Surg"},{"issue":"1","key":"10.1016\/j.eprac.2022.10.005_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"issue":"2","key":"10.1016\/j.eprac.2022.10.005_bib11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/17446651.2018.1449641","article-title":"A\u00a0clinical framework to facilitate selection of patients with differentiated thyroid cancer for active surveillance or less aggressive initial surgical management","volume":"13","author":"Tuttle","year":"2018","journal-title":"Expert Rev Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.eprac.2022.10.005_bib12","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1007\/s00268-021-06185-2","article-title":"Multifocality and progression of papillary thyroid microcarcinoma during active surveillance","volume":"45","author":"Nagaoka","year":"2021","journal-title":"World J Surg"},{"issue":"2","key":"10.1016\/j.eprac.2022.10.005_bib13","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1089\/thy.2020.0330","article-title":"Indications and strategy for active surveillance of adult low-risk papillary thyroid microcarcinoma: consensus statements from the Japan Association of Endocrine Surgery Task Force on management for papillary thyroid microcarcinoma","volume":"31","author":"Sugitani","year":"2021","journal-title":"Thyroid"},{"issue":"2","key":"10.1016\/j.eprac.2022.10.005_bib14","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1089\/thy.2021.0310","article-title":"Invasion of a recurrent laryngeal nerve from small well-differentiated papillary thyroid cancers: patient selection implications for active surveillance","volume":"32","author":"Newman","year":"2022","journal-title":"Thyroid"},{"issue":"3","key":"10.1016\/j.eprac.2022.10.005_bib15","doi-asserted-by":"crossref","first-page":"244","DOI":"10.2174\/1389202918666170105094459","article-title":"The genetics of papillary microcarcinomas of the thyroid: diagnostic and prognostic implications","volume":"18","author":"Rodrigues","year":"2017","journal-title":"Curr Genomics"},{"issue":"8","key":"10.1016\/j.eprac.2022.10.005_bib16","doi-asserted-by":"crossref","first-page":"979","DOI":"10.4158\/EP171805.RA","article-title":"Role of molecular markers in thyroid nodule management: then and now","volume":"23","author":"Nikiforov","year":"2017","journal-title":"Endocr Pract"},{"issue":"25","key":"10.1016\/j.eprac.2022.10.005_bib17","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1200\/JCO.2014.55.5094","article-title":"BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence","volume":"32","author":"Xing","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"issue":"9","key":"10.1016\/j.eprac.2022.10.005_bib18","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1002\/cncr.29934","article-title":"Prognostic effects of TERT promoter mutations are enhanced by coexistence with BRAF or RAS mutations and strengthen the risk prediction by the ATA or TNM staging system in differentiated thyroid cancer patients","volume":"122","author":"Song","year":"2016","journal-title":"Cancer"},{"issue":"15","key":"10.1016\/j.eprac.2022.10.005_bib19","doi-asserted-by":"crossref","first-page":"4256","DOI":"10.1158\/1078-0432.CCR-21-0874","article-title":"Oncogenic mutations in PI3K\/AKT\/mTOR pathway effectors associate with worse prognosis in BRAF(V600E)-driven papillary thyroid cancer patients","volume":"27","author":"Pappa","year":"2021","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.eprac.2022.10.005_bib20","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.surg.2019.03.040","article-title":"Active surveillance of low-risk papillary thyroid cancer: a meta-analysis","volume":"167","author":"Saravana-Bawan","year":"2020","journal-title":"Surgery"},{"issue":"1","key":"10.1016\/j.eprac.2022.10.005_bib21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.surg.2018.07.045","article-title":"Natural history of papillary thyroid microcarcinoma: kinetic analyses on tumor volume during active surveillance and before presentation","volume":"165","author":"Miyauchi","year":"2019","journal-title":"Surgery"},{"issue":"10","key":"10.1016\/j.eprac.2022.10.005_bib22","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1001\/jamaoto.2017.1442","article-title":"Natural history and tumor volume kinetics of papillary thyroid cancers during active surveillance","volume":"143","author":"Tuttle","year":"2017","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"5","key":"10.1016\/j.eprac.2022.10.005_bib23","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1089\/thy.2018.0609","article-title":"Tumor volume doubling time in active surveillance of papillary thyroid carcinoma","volume":"29","author":"Oh","year":"2019","journal-title":"Thyroid"},{"issue":"12","key":"10.1016\/j.eprac.2022.10.005_bib24","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1089\/thy.2019.0396","article-title":"Kinetic analysis of growth activity in enlarging papillary thyroid microcarcinomas","volume":"29","author":"Ito","year":"2019","journal-title":"Thyroid"},{"issue":"3","key":"10.1016\/j.eprac.2022.10.005_bib25","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1089\/thy.2020.0317","article-title":"Interobserver reproducibility in sonographic measurement of diameter and volume of papillary thyroid microcarcinoma","volume":"31","author":"Chung","year":"2021","journal-title":"Thyroid"},{"issue":"10","key":"10.1016\/j.eprac.2022.10.005_bib26","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1089\/thy.2021.0094","article-title":"Tumor volume doubling time in active surveillance of papillary thyroid microcarcinoma: a multicenter cohort study in Korea","volume":"31","author":"Jin","year":"2021","journal-title":"Thyroid"},{"issue":"6","key":"10.1016\/j.eprac.2022.10.005_bib27","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1001\/jamaoto.2020.0368","article-title":"Association of patient age with progression of low-risk papillary thyroid carcinoma under active surveillance: a systematic review and meta-analysis","volume":"146","author":"Koshkina","year":"2020","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"12","key":"10.1016\/j.eprac.2022.10.005_bib28","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1089\/thy.2018.0263","article-title":"Active surveillance of low-risk papillary thyroid microcarcinoma: a multi-center cohort study in Korea","volume":"28","author":"Oh","year":"2018","journal-title":"Thyroid"},{"issue":"2","key":"10.1016\/j.eprac.2022.10.005_bib29","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1210\/jc.2017-01775","article-title":"High serum TSH level is associated with progression of papillary thyroid microcarcinoma during active surveillance","volume":"103","author":"Kim","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.eprac.2022.10.005_bib30","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/cen.14415","article-title":"Impact of high-quality ultrasound following community ultrasound on surgical planning and active surveillance in patients with thyroid cancer","volume":"94","author":"Cohen","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"12","key":"10.1016\/j.eprac.2022.10.005_bib31","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.4158\/EP-2020-0201","article-title":"Quality of life in patients with low-risk papillary thyroid microcarcinoma: active surveillance versus immediate surgery","volume":"26","author":"Nakamura","year":"2020","journal-title":"Endocr Pract"},{"issue":"3","key":"10.1016\/j.eprac.2022.10.005_bib32","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1210\/clinem\/dgaa889","article-title":"Effect of initial treatment choice on 2-year quality of life in patients with low-risk papillary thyroid microcarcinoma","volume":"106","author":"Moon","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.eprac.2022.10.005_bib33","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1089\/thy.2018.0624","article-title":"Longitudinal assessment of quality of life according to treatment options in low-risk papillary thyroid microcarcinoma patients: active surveillance or immediate surgery (interim analysis of MAeSTro)","volume":"29","author":"Kong","year":"2019","journal-title":"Thyroid"},{"issue":"7","key":"10.1016\/j.eprac.2022.10.005_bib34","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1089\/thy.2018.0711","article-title":"Quality of life in patients with papillary thyroid microcarcinoma managed by active surveillance or lobectomy: a cross-sectional study","volume":"29","author":"Jeon","year":"2019","journal-title":"Thyroid"},{"issue":"4","key":"10.1016\/j.eprac.2022.10.005_bib35","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1001\/jamaoto.2018.4131","article-title":"Patient experience of thyroid cancer active surveillance in Japan","volume":"145","author":"Davies","year":"2019","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"1","key":"10.1016\/j.eprac.2022.10.005_bib36","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1001\/jamaoto.2020.4200","article-title":"Thyroid cancer active surveillance program retention and adherence in Japan","volume":"147","author":"Davies","year":"2021","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"1","key":"10.1016\/j.eprac.2022.10.005_bib37","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1097\/SLA.0000000000004417","article-title":"Barriers to the use of active surveillance for thyroid cancer: results of a physician survey","volume":"276","author":"Hughes","year":"2022","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.eprac.2022.10.005_bib38","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.amjsurg.2020.11.021","article-title":"Factors associated with physicians' recommendations for managing low-risk papillary thyroid cancer","volume":"222","author":"McDow","year":"2021","journal-title":"Am J Surg"},{"issue":"10","key":"10.1016\/j.eprac.2022.10.005_bib39","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1089\/thy.2018.0105","article-title":"Thyroid cancer treatment choice: a pilot study of a tool to facilitate conversations with patients with papillary microcarcinomas considering treatment options","volume":"28","author":"Brito","year":"2018","journal-title":"Thyroid"},{"issue":"7","key":"10.1016\/j.eprac.2022.10.005_bib40","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1089\/thy.2019.0592","article-title":"A\u00a0prospective mixed-methods study of decision-making on surgery or active surveillance for low-risk papillary thyroid cancer","volume":"30","author":"Sawka","year":"2020","journal-title":"Thyroid"},{"key":"10.1016\/j.eprac.2022.10.005_bib41","doi-asserted-by":"crossref","first-page":"6721","DOI":"10.2147\/CMAR.S317627","article-title":"Cost-effectiveness analysis of active surveillance compared to early surgery in small papillary thyroid cancer: a systemic review","volume":"13","author":"Baek","year":"2021","journal-title":"Cancer Manag Res"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X22006462?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X22006462?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T06:05:00Z","timestamp":1722060300000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X22006462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S1530891X22006462"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2022.10.005","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Active Surveillance for Low-Risk Differentiated Thyroid Cancer","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2022.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 AACE. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}